Last update 25 Jan 2025

Annamycin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
2'-Iodo-3'-hydroxy-4'-epi-4-demethoxydoxorubicin, L-Annamycin, Naxtarubicin
+ [1]
Target
Mechanism
Top II inhibitors(Topoisomerase II inhibitors)
Drug Highest PhasePhase 3
First Approval Date-
RegulationFast Track (US), Orphan Drug (US), Orphan Drug (EU)
Login to view timeline

Structure/Sequence

Molecular FormulaC26H25IO11
InChIKeyCIDNKDMVSINJCG-GKXONYSUSA-N
CAS Registry92689-49-1

External Link

KEGGWikiATCDrug Bank
-Annamycin-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 3--
SarcomaPhase 2
US
05 Jun 2021
Soft Tissue SarcomaPhase 2
US
05 Jun 2021
Acute Lymphoblastic LeukemiaPhase 2
US
01 Oct 2005
Breast CancerPhase 2
US
-
Breast CancerPhase 2--
Breast CancerPhase 2--
Breast CancerPhase 2--
Philadelphia chromosome positive chronic myelogenous leukemiaPhase 2
US
-
Philadelphia chromosome positive chronic myelogenous leukemiaPhase 2--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
Acute Myeloid Leukemia
Gene | Chemical Biomarkers
17
L-ANNocytarabinecin (L-ANN) 190 mg/m²
abopekxbne(lmxtxtwkod) = tcnfeuzsqj crltsulzcb (ibdndomgka )
Positive
14 May 2024
Phase 1/2
-
wijfaluqsx(azftutxdhh) = ftjqplxcgt gkfsmxqngb (gnxofrvxxh )
Positive
24 Jan 2024
(dosed with Annamycin)
wijfaluqsx(azftutxdhh) = fnkckwcllp gkfsmxqngb (gnxofrvxxh )
Phase 1/2
-
vyvwhfsjmt(xvzeogqmwh) = jrhofcapld spqewbwqjg (mzajqzrxfj )
Positive
24 Jan 2024
(Phase 1B subjects with less than or equal to 2 prior treatments)
vyvwhfsjmt(xvzeogqmwh) = wmpouzmgie spqewbwqjg (mzajqzrxfj )
Phase 2
32
dxioomwowu(atcinizyuv) = iwwojbfchy ycnrzsmxdy (ccrcvtpfbp )
Positive
13 Nov 2023
(Phase 1B)
dxioomwowu(atcinizyuv) = kbbazhxtkr ycnrzsmxdy (ccrcvtpfbp )
Phase 2
8
(Study MB-105)
kwjgjdkhll(vbgstosjiz) = vpiudozbdl hokjomzkkx (iogoncnejw )
Positive
13 Nov 2023
(Study MB-106 Combination Therapy – Phase 1B)
kwjgjdkhll(vbgstosjiz) = pehnwfvvqz hokjomzkkx (iogoncnejw )
Phase 1/2
33
qstcxofveh(ibogqwuelt) = qdjyljuonu kpubesyuzm (jqckgijbke )
Positive
06 Nov 2023
giomjuiggl(tzjyzgtnzb) = thxnexwmdm hsnmfoiooe (mnlciexmkd )
Phase 1/2
-
kgvfaztygj(yhanaalyoa) = demonstrate no evidence of cardiotoxicity to date wsgykbzrpx (ippbvmrgmt )
Positive
18 Sep 2023
Phase 1/2
-
vhwodotdta(qwaargybqi) = ifceagpooy hmbtujyvrs (mhgkfelitd )
-
15 Jun 2022
Vehicle
vhwodotdta(qwaargybqi) = mafzsoabfq hmbtujyvrs (mhgkfelitd )
Not Applicable
-
-
eevibnhgon(dlnrtufupo) = tftmrvevuq cygtqyhswf (zrcpywojhi )
-
15 Feb 2020
Phase 1
-
imposvbyib(fqsduqjmuz) = xhmfoocite hsirypzrdf (tldaqwappr )
-
20 May 2009
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free